{"id":"49a0443e-3414-40a3-9f90-cadc315966ae","modelId":"4e82b737-eeed-40fa-96b8-c426df7e5c52","versionId":null,"locationId":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","operatorId":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","ownerId":null,"slug":"motif-bci-germany-europe","status":"operational","firstSeen":"2024-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["identity_verification","access_control","security_screening"],"shiftStructure":null,"hoursPerDay":24,"siteType":"commercial","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"medium_11_100","siteEnvironment":"indoor","operatorType":"customer_deployed","sourceQualityTier":8,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[],"notes":"Commercial product — available for purchase in this market.","keyFacts":[],"reviewNote":"Bulk deepened — form-factor-based metadata assignment","exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"retail","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-20T04:09:15.144Z","updatedAt":"2026-08-20T16:27:55.889Z","model":{"id":"4e82b737-eeed-40fa-96b8-c426df7e5c52","companyId":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","modelName":"Motif BCI","slug":"motif-bci","description":"Wirelessly powered implantable BCI delivering targeted brain stimulation for treatment-resistant depression.","formFactor":"biometric","industryVertical":"healthcare","environment":"indoor","maturityStage":"pilot","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form Factor","value":"biometric"},{"label":"Maturity","value":"pilot"},{"label":"DOT implant","value":"Rice's April 28, 2026 report says Motif Neurotech's Digitally programmable Over-brain Therapeutic (DOT) is a wirelessly powered implant about the size of a blueberry that sits in the skull above the dura, without touching the brain, and stimulates circuits linked to depression ([Rice University](https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial))."},{"label":"FDA study","value":"The same report says the FDA cleared an early feasibility study for adults with treatment-resistant depression, a group Motif puts at nearly 3 million Americans, and that Motif received the investigational device exemption four years after founding. Named sites include Baylor College of Medicine and Massachusetts General Brigham ([Rice University](https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial))."}],"createdAt":"2026-08-08T22:32:35.975Z","updatedAt":"2026-10-03T17:50:38.319Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","name":"Motif Neurotech","slug":"motif-neurotech","description":"Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its [Motif BCI](/models/motif-bci) XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.","status":"private","founded":2022,"hq":"Houston, Texas, USA","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-23T21:16:59.827Z","hqAddress":null,"hqPrecision":null,"website":"motifneuro.tech","fundingTotal":"18750000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"keyFacts":[{"label":"FDA","value":"IDE approved April 2026"},{"label":"Indication","value":"Treatment-resistant depression"},{"label":"Program","value":"ARPA-H behavioral health"},{"label":"Origin","value":"Rice University research"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:35.528Z","updatedAt":"2026-08-21T22:31:16.597Z"}},"version":null,"location":{"id":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","name":"Germany, Europe","slug":"germany-europe","kind":"country","parentLocationId":null,"region":"Western Europe","lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-20T04:07:01.358Z","updatedAt":"2026-08-21T03:20:12.226Z"},"operator":{"id":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","name":"Motif Neurotech","slug":"motif-neurotech","description":"Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its [Motif BCI](/models/motif-bci) XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.","status":"private","founded":2022,"hq":"Houston, Texas, USA","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-23T21:16:59.827Z","hqAddress":null,"hqPrecision":null,"website":"motifneuro.tech","fundingTotal":"18750000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"keyFacts":[{"label":"FDA","value":"IDE approved April 2026"},{"label":"Indication","value":"Treatment-resistant depression"},{"label":"Program","value":"ARPA-H behavioral health"},{"label":"Origin","value":"Rice University research"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:35.528Z","updatedAt":"2026-08-21T22:31:16.597Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/motif-bci-germany-europe","url":"https://registry.deploy.report/deployments/motif-bci-germany-europe","name":"Motif BCI at Germany, Europe","identifier":"49a0443e-3414-40a3-9f90-cadc315966ae","startDate":"2024-06-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/germany-europe","name":"Germany, Europe"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/motif-neurotech","name":"Motif Neurotech"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/motif-bci","name":"Motif BCI"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"claimed-not-verified","maturity_stage":"pilot","lifecycle_state":"active","architectural_position":{"cohort":"biometric","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}